Risk of advanced diabetic nephropathy in carriers of the Q variant of ENPP1 according to duration of type 1 diabetes
| . | Renal status . | ||
|---|---|---|---|
| Control subjects . | Proteinuria subjects . | ESRD subjects . | |
| Diabetes duration <24 years | |||
| Noncarriers of Q variant, (n) | 112 | 82 | 48 |
| Carriers of Q variant (n) | 27 | 32 | 27 |
| Odds ratio | 1.0 | 1.6 | 2.3 |
| 95% CI | Reference | 0.9–2.9 | 1.2–4.4 |
| Diabetes duration ≥24 years | |||
| Noncarriers of Q variant, (n) | 129 | 55 | 55 |
| Carriers of Q variant (n) | 39 | 31 | 22 |
| Odds ratio | 1.0 | 1.9 | 1.3 |
| 95% C.I. | Reference | 1.1–3.3 | 0.7–2.4 |
| . | Renal status . | ||
|---|---|---|---|
| Control subjects . | Proteinuria subjects . | ESRD subjects . | |
| Diabetes duration <24 years | |||
| Noncarriers of Q variant, (n) | 112 | 82 | 48 |
| Carriers of Q variant (n) | 27 | 32 | 27 |
| Odds ratio | 1.0 | 1.6 | 2.3 |
| 95% CI | Reference | 0.9–2.9 | 1.2–4.4 |
| Diabetes duration ≥24 years | |||
| Noncarriers of Q variant, (n) | 129 | 55 | 55 |
| Carriers of Q variant (n) | 39 | 31 | 22 |
| Odds ratio | 1.0 | 1.9 | 1.3 |
| 95% C.I. | Reference | 1.1–3.3 | 0.7–2.4 |